Behind The Labs

Behind The Labs

A podcast where we explore new studies in the world, relating to biological advancements and more, and we also speak to experts on these topics. Get ready to learn more about what goes on Behind The Labs!

  1. 23 JAN

    Behind The Labs - Episode 49 - Preventing Crohn's Disease in Advance, Ibuprofen as a Preventative Measure to Cancer, and Exercise's Best Effects!

    In this episode, we dive into a series of powerful new studies showing how early detection, lifestyle choices, and cutting-edge therapies are reshaping the future of medicine. We begin with groundbreaking research from Sinai Health revealing a blood test that may predict the risk of Crohn’s disease years before symptoms appear—opening the door to prevention rather than damage control. From there, we explore work from the AdventHealth Research Institute showing that consistent aerobic exercise can make the brain appear biologically younger, highlighting how everyday habits in midlife may protect long-term cognitive health. We then turn to transformative findings from Stanford Medicine, where scientists successfully regenerated joint cartilage in aging and injured mice by blocking an aging-related enzyme—raising real hope for disease-modifying treatments for osteoarthritis that could reduce the need for joint replacement. The episode also covers long-term results from the RECOVER trial led by Washington University School of Medicine, where vagus nerve stimulation produced sustained, life-changing improvements for people with the most severe forms of treatment-resistant depression. Finally, we unpack emerging (and controversial) evidence suggesting that ibuprofen’s anti-inflammatory effects may influence cancer risk—while emphasizing why self-medication is not the answer. Together, these studies paint a compelling picture: medicine is moving earlier, deeper, and more personalized—shifting from managing symptoms to predicting risk, restoring function, and improving quality of life over the long term.

    28 min
  2. 24/12/2025

    Behind The Labs - Episode 48 - Alzheimer's Early Prevention, CBD+THC's Defence Against Alzheimers', and Alcohol's Correlation with Cancer!

    In this episode of Behind the Labs, we zoom out and connect the dots across some of the most compelling recent research shaping how we think about health, disease, and prevention. We explore how scientists are uncovering the earliest biological triggers of Alzheimer’s disease, from toxic amyloid subtypes and reactive astrocytes to experimental drugs that may stop damage before memory loss begins. We also dive into breakthrough work on mitochondria and healthy aging, where boosting cellular energy production extended both lifespan and healthspan in animal models—improving metabolism, endurance, and reducing markers of cellular aging. We then turn to the often-overlooked parts of our genome, discussing how researchers are mapping hidden DNA switches in astrocytes that regulate brain genes linked to Alzheimer’s and other neurological disorders, and how AI models are now being trained on this data. Finally, we tackle real-world prevention, breaking down large-scale evidence on alcohol use and cancer risk, and emerging research on cannabis-derived compounds as potential cancer therapies. From molecular mechanisms to public health implications, this episode ties together how early intervention, gene regulation, metabolism, and lifestyle intersect—offering a big-picture view of where modern biomedical research is heading, and what it could mean for the future of medicine. 🧠🧬🔬

    36 min

About

A podcast where we explore new studies in the world, relating to biological advancements and more, and we also speak to experts on these topics. Get ready to learn more about what goes on Behind The Labs!